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Chick periosteum-derived cells, which do not enter thechondrogenic cell lineage during normal bone development and growth, exhibit chondrogenic 
potential in high cell density culture conditions. In such cultures, collagen gene expression was temporally analyzed at the mRNA level by a reverse 
transcription PCR (RT-PCR) procedure. which showed that ~11.11) and al(IX) collagen mRNAs arc coordinately increased, coincident with the 
onset of overt chondrogenesis, and subsequently decreased as chondrocytes exhibited hypertrophic characteristics. 01(x) collagen mRNA was 
detected well before the onset of chondrogenesis and markedly increased along with the hypcrtrophic hange. For al(I) collagen, both the 
bone/tendon form and the cartilage form of mRNA were detected throughout he culture period. This culture system provides an experimental 
vehicle capable of investigating !h? molecular events involved in the full range of chondrogenic differentiation starting from uncommitted 
periasteum-derivcd mcsenchymal stem cells, 
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1. INTRODUCTION 
The periosteum, the outer layer of bone, plays a cru- 
cial role in the radial growth of long bone; mesenchymal 
stem cells [I] in the periosteum differentiate directly to 
osteoblasts and never enter a chondrogenis lineage in 
normal long bone development and growth. In fracture 
healing, however, periosteum-derived mesenchymal 
cells differentiate into chondrocytes with subsequent en- 
dochondral bone formation [2]. Thus, cells in the peri- 
osteum appear to possess the potential to differentiate 
into not only osteoblasts but also chondrocytes under 
certain conditions [33. In this regard, we have previously 
reported that chick periosteum-derived mesenchymal 
cells, when plated at a high cell density in culture, ex- 
hibit chondro-osteogenic phenotypes in vitro [4]. Many 
cell culture systems whZr induce chondrogenesis in 
vitro have been reported [S-7]; however, these are cul- 
tures of cells which are already committed to differenti- 
ate into chondrocytes. Our culture system is of interest 
because chondrogenesis occurs from undifferentiated 
cells which are not committed to chondrocytes in the 
normal course of bone 1 jhysiology or development. To 
investigate the different;.ation of chondrocytes and the 
formation of hypertrophic artilage from uncommitted 
periosteum-clerived cells :it the molecular level, we have 
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used this periosteum-derived mesenchymal cell culture 
system. In this report, the temporal changes are 
presented for type I, II, IX and X collagen mRNAs 
during an early phase of chondrogenesis from chick 
periosteum-derived cells. 
2. MATERIALS AND METHODS 
Periosteal cells were prepared as described elsewhere [4], Briefly, 
tihial periostea of I-week-old White Leghorn chicks were digested 
with collagenasc-trypsin a d the liberated cells were sparsely plated 
at a cisnsity of I.0 x i06 cells per 100 mm plastic tissue culture dish 
in EGJb medium (Gibco Lab.) supplemented with 10% felal calf 
serum (FCS) (Gibco Lab.). After IO-12 days of primary crrirure, when 
these cells reached confluence, they were replated at a density 01’ I,O 
x IO” cells per 50 p! micromass (high cell density culture [8]). The day 
of introduction into the high density culture was designated as day 0. 
BGJb medium supplemented with 10% FCS was changed every other 
day; startirig on day 1, freshly prepared ascorbic acid (sodium as- 
corbatc, Sigma Chemical Co.) was added daily at a final concentration 
of 50 yg/m!. For light microscopic observation, cell cultures were 
peclcd off the dishes and processed for parafin sections perpendicular 
to the culture dishes. These sections were stained with Toluidine blue 
(0.1%. pH 7.0); some sections were treated with von Kossa stain 
followed by counterstaining with Toluidine blue. 
2.2. Cylophsttth RNA e,xirrrrtion and reverse rrartscripriott-PCR (RT- 
PCR) Wily5L 
Cytoplasmic RNA was extracted from the cultured cells on day 5 
of the primary culture end day 2,4.6,9, I2 and I5 of the secondary 
high density culture with a Cytoplasmic RNA Extraction Kit (5 Prime- 
? Prime LX., Pennsylvania). As a control, cytoplnsmic RNA was also 
extracted from chick muscle fibroblasts, skin fib:oblasts and sternal 
chondrocytcs of I S-day embryos, and liver. 
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500 ng ofcytoplasmic RNA was reverse transcribed to make cDNA 
with random hcxamcr as a primer following a previously described 
method [9]. PCR was perfomlcd with 3 ~1 out of 80 ~1 of the cDNA 
aliquot as a template with Thmt~us rhemmpr”tilus (Tth) DNA po- 
lymerase (Toyobo Co., Osaka). A combination of 5’ and 3’ primers 
derived from separate xons was used to detect specific collagen 
mRNAs (Fig. 1). For a?(I) procollagen, two different 5’ primers were 
prepared to detect both the bone/tendon form of mRNA and the 
cartilage form of mRNA [IO]. In preliminary experiments, various 
PCR conditions were tested with different amounts of cytoplasmic 
RNA from sternal chondrocytes :o find the conditions wherein difler- 
em amounts ofcollagen mRNA proportionally affect he yield of PCR 
products. The following conditions were adopted in the present study: 
42 cycles performed with Zymoreactor (Atto Co., Tokyo) at 94OC for 
I min, 61’C for 2 min, 72% for 3 min and 72°C for 6 min at the end 
of the cycles with 5 pmol of each pair of primers and 1 S mM MgCl,. 
Equal aliquots of PCR products were then separated on an agarosti 
gel. Southern blot analysis of the PCR products were pcrformcd as 
described previously [I I]. The cDNA clones, pYN2142(al(II)) [12], 
pYNl738(al(IX)) [I31 and pYN92E(al(X)) [14] were used for hy- 
bridization. 
3. RESULTS 
3.1. Trmsition of cell culture 
The cellular and morphological transitions of high 
mRNA 
A ,(bpl 
al (II) 333 
cartilage 
B 
S 6ense 5 '-GCAGAGACCATCAACGGCGGT-3' 
al (II) rantisense 5'-CAGGCGCGAGGTCTTCTGCGA-3' 
al (IX) 
5' sense 5’-CAGClGGCAGCCAGTC~AGTAGO-3’ 
3’ antisense 5 ’ -CTCTGTCCAGCCTGCGG-3 ' 
alO9 
B'6Nl66 5'-AAGGGGCCACCACACTT?.-3' 
3’antisense 5'-TTCTCCAGGCTTCCCTATCCC-3' 
5’ sense 5'-TTACTCCTCGCGACTGTATGC-3' 
a2(l) *s 6ell6e 5 '-TGCACGGAAGGAT-3' 
3’anttsense 5 a-GcmccAGGAAcAcCTTGAA-3' 
Fig. I. Primers used for RT-PCR. analysis of collagen mRNAs. (A) 
The ehadd boxes indicate exons and lines indicate introns of each 
collagen gene. The cxuns are numbered from the 3’ end in al(H) and 
al(lX) collagen genes and from the Send in al(X) and a?(I) collagen 
genes. The arrowheads indicate approximate locations of synthetic 
oligonucleotidc primers used in this study. The numbers on the right 
show the predicted lengths of RT-PCR products from each collagen 
mRNA, The primer with the asterisk was prepared within the car- 
tilagc-specific exon a d the number with lhk tdr-risk is the predicted 
length of the KT-PCR product from the cartilage form of a2(1) 
mRNA. (B) The sequences of the primers were selected from published 
data [12,13,21-231. 
Fig. 2. Morphologic appearance of the culture. (A) Phase photomi- 
crograph of periostcumdcrived mescnchymal cells in the primaty 
culture. (B) Perpendicular section of day 9 of the secondary high 
density culture (Toluidine blue staining). (C) Perpendicular section of 
day IS culture (von Kossa stain counterstaincd with Toluidine blue). 
Bar in C = 50 pm. 
cell density cultures have been described in detail else- 
where [4]. In brief, periosteum-derived mesencbymal 
cells in primary culture appeared undifferentiated and 
homogeneous, a popuiation of i%robhSt-iik cetts (Fig. 
2A). These cells did not express chondrogenic or osteo- 
genic phenotypes as judged by their morphology and 
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immunohistochemical study of antigens specific to 
chondrocytes or osteoblasts [4]. When introduced into 
high cell density culture, these cells first formed a multi- 
layer of flbroblast-like cells, the majority of which dif- 
ferentiated into chondrocytes (Fig. 2B) and further de- 
veloped into hypertrophic hondrocytes (Fig. 2C). Ap 
pearance of type II and type X collagen in the transition 
of this culture has been immunohistochemically de- 
tected as reported previously [4]. The top layer of the 
culture differentiated into bone tissue, as evidenced by 
the mineralization (Fig. 2C) and immunohistochemical 
reactivity to bone Gla protein and osteocyte-specific 
probes (see ref. [4]). These findings indicate that undif- 
ferentiated mesenchymal cells from periosteum have the 
potential to terminally differentiate into either hyper- 
trophic chondrocytes or osteoblasts/osteocytes as con- 
trolled by the local cues due to their relative positions 
in the culture. 
3.2. Detection of colfagen ntRNAs 
Using the PCR conditions described in Materials and 
Methods, titered al(IX) collagen mRNA from sternal 
chondrocytes was proportionally amplified (Fig. 3). 
ccl(D) and al(X) collagen mRNA were also linearly 
amplified under the same conditions (not shown). This 
enabled us to compare the relative level of mRNA for 
the crl(IX), al(I1) and al(X) chain at each phase of the 
culture period. 
orl(II) collagen mRNA was first observed on day 9 of 
secondary culture as a band of predicted size (Fig. 4A). 
The identification of the PCR product as the amplitied 
form of ccl(I1) mRNA was confirmed by the restriction 
mapping (not shown) and Southern Blot analysis (Fig. 
5A). By the Southern blot analysis, small amounts of 
al(B) mRNA were detectable starting on day 4. Com- 
pared to the level of B-octin mRNA, which is almost 
constant among the different ime points (Fig, 4F), type 
II collagen mRNA increased markedly until day 9, 
coincident with the onset of overt chondrogenesis and 
the appearance of positive immunostaining for type II 
collagen as reported in a previous tudy [4], Thereafter, 
type II collagen mRNA decreased until day 15, in paral- 
lel with the progress of chondrocyte hypertrophy in the 
culture. In a similar fashion, al(IX) collagen mRNA 
was first detected on day 4 by Southern blot analysis 
(Fig. SB), reached apeak on day 9, and then decreased. 
Although the al(I1) and arl(IX) collagen genes were 
coordinately expressed uring the chondrocyte dif- 
ferentiation in this culture system, no al(IX) mRNA 
was detected in the control muscle and skin fibroblasts, 
whereas a small amount of al(I1) mRNA was de- 
tectable in these cells (Fig. SA,B). 
Type X collagen gene expression was a!so analyzed 
by RT-PCR and Southern blot, Unexpectedly, type X 
collagen mRNA was detectable throughout he 15-day 
secondary high density culture period (Figs. 4C and 
SC). Although type X collagen mRNA was absent in the 
Fig. 3. Agarosl! gel ele .trophoresis of RT-PCR products tained with 
cthidium bromide. Ddferent amounts of control sternal chondrocyte 
RNA were reverse transcribed an  amplified by PCR with the al(IX) 
collagen-specific primer, The number above each lane indicates the 
amount of sternal chondrocyte RNA :.~.-xl, Note that different 
amounts of RT-PCR products were obtained and these amounts were 
proportionnl to the imput amount of Eternal chondrocyte RNA. 
primary culture, it was detected as early as day 2 of the 
high density secondary culture, which is well before the 
onset of chondrogenesis. Type X collagen mRNA in- 
creased along with the chondrocyte hypertrophy. Type 
X collagen mRNA was not detectable in muscle fi- 
broblasts, skin fibroblasts or liver (Figs. 4C and SC). 
For a2(1) collagen, the expression of the two forms 
of mRNA, namely the bone/tendon form and the car- 
tilage form, was analyzed. The bone/tendon form of 
#2(I) collagen mRNA was detected throughout the 
whole culture period (Fig. 4D); this form of mRNA was 
present in control muscle fibroblasts, skin fibroblasts, 
and liver, but not in sternal chondrocytes. The cartilage 
form of oc2(1) mRNA, which is a major a2(1) transcript 
in cartilaginous tissue [lo], was also detectable through- 
out the culture period (Fig. 4E). The presence of the 
cartilage form of a2(1) mRNA was not restricted to 
cartilage, but was widely distributed among non-carti- 
laginous tissues (Fig. 4E). 
4. DISCUSSION 
The present study confirms that al(I1) and al(IX) 
collagen gene expression is associated with differentia- 
tion of chondrocytes. As speculated previously [ 151, this 
co-expression of types II and IX collagen mRNAs may 
be required for the appropriate assembly of thin fibrils 
in the cartilaginous extracellular matrix. The initiation 
of production of these mRNA species on day 4 of the 
secondary culture, which is about 4 days before the 
onset of overt chondrogenesis, may indicate the time 
around which uncommitted bipotential progenitor cells 
in the periosteum commit to a chondrogenic lineage. It 
should be noted, however, that the presence of a small 
amount of cI 1 (II) mRNA is non-chondrogenic cells may 
indicate the presence of alternatively spliced mRNA 
which exists in pre-chondrogenic cells [16]. 
To our surprise, type X collagen mRNA was de- 
tectable throughout he secondary high density culture 
period, while, in our previous study, immunoreactive 
type X collagen was detectable only after day 12. These 
results suggest hat in the present culture system the 
periosteum-derived cells may express type X collagen 
280 
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P5 SZ s4 S6 s9 512 S15 MF SF C L 
Fig. 4. Agarosc gel clcctrophorcsis of RT-PCR products tained with ethidium bromide. Tota! RNA was isolated from day 5 primary cultures (PS). 
and from day 2 (SZ), day 4 (S4), day 6 (S6). day 9 (S9). day 12 (SI 2) and day 1 S (Sl S) secondary cultures, muscle fibroblasts @IF), skim libroblasts 
(SF), sternal chondrocytcs of ISday embryos (C), and liver (L). RNA samples were amplified with primers spcciEc for (A) al(H) collagen, (B) 
al(tX) collagen, (C) al(X) collagen, (D) the boneltendon term of tz2(1) collagen, (E) the cartilage form of &(I) collagen and (F) /7 actin. 
g6ne before the apparent onset of chondrocyte hyper- 
trophy. During chondrocyte hqertrophy up to day 15 
of culture, type X co!lagen mRNA increased. On the 
other hand, the mRNA for al(H) and al(IX) collagen 
diminished. Similar results have been reported in the 
hypertrophic artilage of chick tibiotarsus and for chon- 
drocytes in suspension culture [15,17,18]. These 
observations together suggest hat a shift occurs from 
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Fig. 5. Southern blot analysis or‘ RT-PCR products. Gels in Fig. 4A, 
4B and 4C were blotted onto nylon membranes and hybridized with 
cDNA probes for (A) al(H) collagen, (B) aI collageu and (C) 
al(X) collgcn. 
type II and type IX collagen to type X collagen when 
chondrocytes become hypertrophic. Although the type 
X collagen mRNA was detected before the appearance 
of type II collagen mRNA, the earlier appearance of 
type X relative to type II collagen gene expression must 
await further analysis, because the efftciencj, of am- 
plification in RT-PCR with different primers is not 
equivalent. 
In this study with RT-PCR, both the bone/tendon 
form and the cartilage form of al?(I) collagen mRNA 
were detectable throughout the culture period. The 
bone/tendon form was absent only in sternal chon- 
drocytes. These results suggest hat the ‘cartilage-spe- 
cific’ promoter is widely utilized in various tissues other 
than cartilage. In addition, the inability of sternal chon- 
drocytes to synthesize the a2 subunit of type I collagen 
[19,20] might result from complete repression of the 
bone/tendon form of a2(1) mRNA. 
It is important to point out that our culture system 
might reflect he in vivo situation for fracture healing. 
In fracture healing, the cells (possibly a population of 
multipotential mesenchymal stem cells) in the peri- 
osteum are believed to proliferate, migrate into the fiac- 
ture site, and differentiate into chondrocytes which, are 
subsequently replaced by bone. This culture system fol- 
lows most of this sequence in vitro. The intrinsic and 
extrinsic factors which govern the chondrogenic or 
osteogenic developmental potential of periosteum- 
derived cells are the subject of future experimentation. 
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